| 000 | 01188 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518083037.0 | ||
| 264 | 0 | _c20210128 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1080/14728222.2020.1724285 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWattiez, Anne-Sophie | |
| 245 | 0 | 0 |
_aCalcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _c02 2020 |
||
| 300 |
_a91-100 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
| 650 | 0 | 4 | _aDrug Development |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _xdrug effects |
| 700 | 1 | _aSowers, Levi P | |
| 700 | 1 | _aRusso, Andrew F | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 24 _gno. 2 _gp. 91-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14728222.2020.1724285 _zAvailable from publisher's website |
| 999 |
_c30581256 _d30581256 |
||